骨髓生成
免疫学
单核细胞
癌症研究
化学
医学
免疫抑制
炎症
生物
细胞生物学
巨噬细胞
免疫系统
粒细胞
作者
Huidong Shi,Zhi-Chun Ding,Ogacheko D. Okoko,Xin Wang,George Zhou,Yan Ye,Md Yeashin Gazi,Caitlin Brandle,Lirong Pei,Rafał Pacholczyk,Catherine C. Hedrick,Locke Johnson Bryan,Gang Zhou
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2026-03-31
卷期号:11 (10)
被引量:1
标识
DOI:10.1172/jci.insight.198360
摘要
Cytotoxic chemotherapy primarily targets rapidly proliferating cancer cells but also depletes normal myeloid cells. The resulting cell loss triggers reactive myelopoiesis, a compensatory process in which hematopoietic stem and progenitor cells in the bone marrow (BM) regenerate myeloid lineages. We previously showed that the alkylating agent cyclophosphamide (CTX) induces myelopoiesis, leading to the expansion of immunosuppressive monocytes in mice. However, the molecular features and clinical relevance of these cells remain poorly understood. Here, we report the emergence of immunosuppressive monocytes in the peripheral blood of lymphoma patients receiving CTX-containing chemotherapy. To gain mechanistic insight into CTX-induced myelopoiesis, we performed single-cell RNA sequencing (scRNA-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) on BM monocytes from CTX-treated mice. These analyses revealed a heterogeneous monocyte population and demonstrated that CTX skews myelopoiesis toward the generation of neutrophil-like monocytes (NeuMo). Moreover, CTX-induced NeuMo cells, enriched within the CXCR4+CX3CR1- monocyte subset, exhibited potent T cell-suppressive activity. Using the NeuMo gene signature, reanalysis of public scRNA-seq datasets identified a transcriptionally similar monocyte subset in chemotherapy-treated cancer patients. Collectively, our findings suggest that the expansion of NeuMo cells following chemotherapy represents a conserved immunoregulatory feedback mechanism with potential impact on tumor response to chemoimmunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI